炎症性肠病中回肠储袋肛管吻合术在表型变化下的长期行为与功能结局
本研究基于单术者前瞻性数据库纳入138例炎症性肠病回肠储袋肛管吻合术患者,中位随访22.5年,由胃肠道病理专家重新评估初始结肠切除标本。39.1%的患者组织学诊断发生变化,10年和20年随访时分别有19%和39%出现克罗恩病样疾病行为;克罗恩病样患者储袋失败率更高(31.1% vs 13.0%,P < .05),但多数仍保持储袋。
要点
- 中位随访22.5年,39.1%患者经病理专家复核后组织学诊断改变。
- 10年和20年随访时分别19%和39%出现克罗恩病样疾病行为。
- 克罗恩病样患者储袋失败率31.1% vs 13.0%(P < .05),但68.9%维持肠道连续性。
核心结论
- 回肠储袋肛管吻合术后组织学和临床诊断改变患者的患者报告结局不明确。
- 尽管储袋切除和生物制剂使用率更高,许多克罗恩病样患者仍保留储袋。
- 诊断改变和储袋失败常发生在回肠储袋肛管吻合术创建10年之后。
- 这支持在精心选择的炎症性肠病患者中考虑结肠切除术后行回肠储袋肛管吻合术,即使组织学不明确,并需要密切长期随访。
研究设计与样本
- 从单术者前瞻性数据库(1991年至2017年共1,165例患者)中识别炎症性肠病回肠储袋肛管吻合术患者。
- 邀请患者完成储袋功能和生活质量评估;无法联系者通过医疗记录获取临床结局和主观功能评估。
- 由专科胃肠道病理学家重新评估初始结肠切除标本。
- 比较组织学评估不一致与一致患者以及后续炎症性肠病行为亚组之间的数据。
- 纳入分析的138例患者中位随访22.5年(范围:5-39年)。
主要发现
- 39.1%的患者在胃肠道病理学家复核后出现组织学诊断改变。
- 10年和20年随访时分别有19%和39%的患者出现克罗恩病样疾病行为。
- 各诊断改变亚组间储袋功能和生活质量评分相似。
- 克罗恩病样疾病患者储袋失败率更高(31.1% vs 13.0%,P < .05)。
- 克罗恩病样患者中68.9%维持肠道连续性,57.9%需要使用生物制剂。
临床怎么用
- 原文结论支持在精心选择的炎症性肠病患者中考虑结肠切除术后行回肠储袋肛管吻合术,即使组织学不明确(作者结论)。
- 作者指出需要密切长期随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ileal-pouch-anal anastomosis is the operation of choice after proctocolectomy for ulcerative colitis; some patients will develop Crohn's disease. We aim to determine long-term behavior and outcomes of inflammatory bowel disease-ileal-pouch-anal anastomosis after colectomy, where a specialist gastrointestinal pathologist re-evaluated the initial colectomy specimen. METHODS: Patients with inflammatory bowel disease-ileal-pouch-anal anastomosis were identified from a single-surgeon prospective database containing 1,165 patients accrued from 1991 to 2017 and invited to complete pouch-function and quality-of-life assessments. Medical records were used to obtain clinical outcomes and subjective functional assessments for those unable to be contacted. Data were compared between patients with and without histological assessment disagreement and subsequent inflammatory bowel disease behavior subgroups. RESULTS: For 138 patients included in the analysis, the median follow-up was 22.5 (range: 5-39) years. A total of 39.1% of patients had histologic diagnostic change after gastrointestinal pathologist review, and 19% and 39% developed Crohn's disease-like disease behavior at 10- and 20-year follow-ups. Pouch function and quality-of-life scores were similar across diagnostic change subgroups. Pouch failure was higher in Crohn's-like disease (31.1 vs 13.0%, P < .05). Intestinal continuity was maintained in 68.9% of Crohn's disease-like patients, 57.9% required biologics. Gastrointestinal pathologist review did not alter the time to new diagnosis (P = .419) or time to pouch failure (P = .320), mean: 11.0 and 11.41 years, respectively. CONCLUSION: We describe equivocal patient-reported outcomes in patients with ileal-pouch-anal anastomosis and changing histologic and clinical diagnosis. Although pouch excision and biologic use rates are higher, many Crohn's disease-like patients maintain their pouch. Diagnostic change and pouch failure often occur >10 years after ileal-pouch-anal anastomosis creation. This supports the consideration of ileal-pouch-anal anastomosis after colectomy in carefully selected patients with inflammatory bowel disease, even those with ambiguous histology and the need for close long-term follow-up.
引用
- Macleod A, Parks MA, Cook CN, et al. Long-term behavior and functional outcomes of ileal-pouch anal anastomosis in inflammatory bowel disease with changing phenotype. Surgery. 2023. PMID: 37802743. doi:10.1016/j.surg.2023.07.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。